Formulation Development, in-vitro and in-vivo evaluation of novel solid oral dosage form containing Quetiapine nanoparticles.

International Journal of Drug Delivery

View Publication Info
 
 
Field Value
 
Title Formulation Development, in-vitro and in-vivo evaluation of novel solid oral dosage form containing Quetiapine nanoparticles.
 
Creator Gubbala, Lakshmi Prasanna; Integrated Product Development, IPDO-Innovation Plaza, Dr Reddys Laboratories Limited, Survey Nos. 42,45, 46 & 54, Bachupally, Qutubullapur Mandal, Ranga Reddy District- 500072, AP India.
Arutla, Srinivas; Head-Product Development; Apotex Research Private Limited, Bangalore.
Venkateshwarlu, Vobalaboina; Managing Director, Neuheit pharma technologies Private Limited, Hyderabad.
 
Subject Pharamaceutical sciences; Pharmaceutical technology; Pharmaceutics; Drug Delivery
Quetiapine Fumarate, Nanoparticles, high pressure homogenization, Particle size
 
Description Poorly water soluble drugs such as quetiapine fumarate (QF) offer challenges in developing a solid dosage form such as tablets with adequate bioavailability. The objective of the present work is to develop a solid dosage form for quetiapine nanoparticles in order to increase the saturation solubility, rate of dissolution so that the oral bioavailability is enhanced. Quetiapine fumarate is a BCS class II drug, hence its oral bioavailability is dissolution limited. To enhance the oral bioavailability a nanoparticle formulation of QF was prepared by using high pressure homogenization. The nanosuspension prepared was converted into dry powder by using spray drying. The nanosuspension and spray dried nanoparticles are characterized for particle size, polydispersity index, zeta potential, saturation solubility, drug content, dissolution rate, solid state characterization such as X-ray diffraction(XRD), Differential scanning calorimetry(DSC), infrared(IR), scanning electron microscopy(SEM), transmission electron microscopy(TEM). The spray dried nanoparticles were blended with excipients to convert into solid dosage form such as tablets. The compressed tablets were evaluated for physical parameters, assay and dissolution was compared with the commercial QF formulation. Solid state characterization data showed loss of drug crystallinity after homogenization. The novel dosage form has shown significant increase in the rate of dissolution when compared to microparticle formulation in discriminating medium. In-vivo studies have shown that the rate and extent of absorption of nanoparticle formulation was significantly high when compared to its microparticle formulation when administered in rats.
 
Publisher Advanced Research Journals
 
Contributor Dr Reddys Laboratories Limited
 
Date 2016-08-22
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier http://www.arjournals.org/index.php/ijdd/article/view/1840
 
Source International Journal of Drug Delivery; Vol 8, No 2 (2016): International Journal of Drug Delivery; 37-49
0975-0215
 
Language eng
 
Relation http://www.arjournals.org/index.php/ijdd/article/view/1840/pdf
 
Rights Copyright (c) 2016 Lakshmi Prasanna Gubbala
http://creativecommons.org/licenses/by-nc-nd/4.0
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library